Fear that outlives its trigger — how anxiety disorders are defined, measured and treated, and where screening stops and diagnosis begins.
Anxiety is a normal alarm. It narrows attention, primes the body for action and helps performance up to a point — the inverted-U every student feels before an exam. It becomes a disorder only when the response is out of proportion to the threat, persists after the threat has gone, or starts to dictate what a person can do.
The anxiety disorders share that core but differ in their trigger: generalised anxiety disorder (GAD) attaches to many everyday concerns, panic disorder to sudden surges of fear, social anxiety to scrutiny by others, and phobias to specific objects or situations. Obsessive-compulsive and trauma-related conditions sit nearby but are classified separately.
GAD is defined less by any single fear than by uncontrollable worry across several domains — work, health, money, family — on more days than not for at least six months. Alongside it come restlessness, being easily fatigued, poor concentration, irritability, muscle tension and disturbed sleep.
The worry is not useful problem-solving. It is repetitive, hard to stop and often about things the person cannot control, so it consumes time and attention without resolving anything. Many people with GAD have lived with it so long that the tension feels like personality rather than a condition.
The WHO estimates that anxiety disorders affect roughly 300 million people worldwide, and they are among the most common mental-health conditions. GAD specifically has a lifetime prevalence of around 5–6%, with women affected about twice as often as men, and an onset that is usually in early adulthood.
They are also costly. Anxiety disorders commonly co-occur with depression, and the combination drives more impairment than either alone. The WHO counts them among the leading contributors to years lived with disability, and, as with depression, the majority of people affected never receive treatment.
The GAD-7 is the standard brief screen. Seven items ask how often, over the past two weeks, a person has been bothered by nervousness, uncontrollable worry and related symptoms, each scored 0–3 for a total of 21. A cut-off of 10 gives sensitivity around 89% and specificity around 82% for GAD.
The GAD-7 tracks severity over time and is short enough for routine use, but it does not diagnose. A high score shows the question is worth asking, not that the answer is known; diagnosis still needs a clinical interview that weighs duration, impairment, other conditions and physical causes of the symptoms.
For mild presentations, guidelines favour active monitoring, psychoeducation and structured psychological therapy. Cognitive behavioural therapy has the largest evidence base, and exposure-based approaches are central for the phobic and panic disorders; for GAD, CBT and applied relaxation are first-line.
Medication — most commonly SSRIs and SNRIs — is considered for moderate to severe presentations or when therapy is unavailable, and combination treatment is common. Regular exercise, sleep and reduced caffeine help manage arousal but support treatment rather than replace it.
Anxiety is not dangerous by itself, but severe panic can feel like a heart attack, and anxiety that drives avoidance or withdrawal can shrink a life quickly. Anyone whose anxiety is stopping them from working, studying or leaving the house should seek assessment rather than wait for it to pass.
This page is educational. It explains what the instrument measures and what the evidence says; it is not a diagnosis and not a substitute for assessment by a qualified clinician.